DCODE
LIVE

Serial Number

79257674

Owner

Immudex ApS

Attorney

Miriam D. Trudell

Filing Date

Dec 6, 2018

Add to watchlist:

No watchlists yet
View on USPTO

DCODE Trademark

Serial Number: 79257674 • Registration: 6026139

DCODE is a trademark filed by Immudex ApS on December 6, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Immudex ApS (8 trademarks)

Bredevej 2A

Entity Type: 99

Trademark Details

Filing Date

December 6, 2018

Registration Date

April 7, 2020

Published for Opposition

January 21, 2020

Goods & Services

Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, including cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other medical therapies, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases, and for use in connection with medical procedures and diagnosis, namely, transplantation, immune monitoring, and vaccines and T-cell monitoring

Chemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research purposes of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis for research purposes of infectious diseases, autoimmunity and for use in connection with toxicological studies and research in relation to transplantation, immune monitoring, vaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 7, 2025 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 14, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 14, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 14, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 14, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 14, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 14, 2023 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2023 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 21, 2022 ADCH
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 12, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 12, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 12, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 12, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 12, 2021 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 5, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 14, 2020 FICS
FINAL DISPOSITION PROCESSED
Aug 14, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 7, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 7, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 21, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jan 17, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 1, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 1, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 17, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2019 CRFA
ASSIGNED TO LIE
Dec 11, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2019 TROA
REFUSAL PROCESSED BY IB
Jun 22, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 5, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 5, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 11, 2019 RFCR
NON-FINAL ACTION WRITTEN
May 10, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
May 10, 2019 MAFR
ASSIGNED TO EXAMINER
May 6, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 2, 2019 REPR